Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer.

Saved in:
Bibliographic Details
Title: Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer.
Authors: Chan Wah Hak C; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Patin EC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Patrikeev A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Nicastri A; Functional Proteomics Group, The Institute of Cancer Research, London, United Kingdom., Kozik Z; Functional Proteomics Group, The Institute of Cancer Research, London, United Kingdom., Baldock H; Biological Services Unit, The Institute of Cancer Research, London, United Kingdom., Kyula-Currie JN; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Roulstone V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Wongariyapak A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Gifford V; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Tenev T; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Appleton ES; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Hubbard LC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Foo S; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Pedersen M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Choudhary JS; Functional Proteomics Group, The Institute of Cancer Research, London, United Kingdom., Ono M; Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom., Melcher AA; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Rullan A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
Source: Cancer research communications [Cancer Res Commun] 2025 Nov 01; Vol. 5 (11), pp. 2079-2091.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2767-9764
DOI:10.1158/2767-9764.CRC-25-0604